Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN16138250) titled 'The CASBAH Study' on March 11.
Study Type: Observational
Study Design:
Cross sectional study
Primary Sponsor: Imperial College London
Condition:
Human immunodeficiency virus [HIV] disease
Infections and Infestations
Intervention:
This is a prospective, observational, single-centre clinical study.
Twenty (20) persons with HIV, who have stopped daily oral antiretroviral therapy and are participating in a clinical trial which involves the administration of bNAbs, will be enrolled.
Potentially eligible participants will be asked to provide their informed consent and attend their routine research clinic for a...